Biocon Chief Urges Middle-Ground On IP Dispute With Other Nations
This article was originally published in PharmAsia News
Executive Summary
Biocon Chairman and Managing Director Kiran Mazumdar-Shaw is urging a middle-ground approach by India drug makers to the continuing U.S. pressure on intellectual-property issues, but said they would not be bullied.